Banca Mediolanum (BMED) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
9 Jul, 2026Executive summary
Net income for H1 2025 reached €477.3 million, up 6–6.1% year-over-year, driven by resilient core business, robust net inflows, and effective commercial initiatives.
Assets under administration and management hit a record €144.4 billion, up 4–12% from year-end 2024, supported by strong net inflows and expanding customer base.
Customer base neared 2 million, with Family Banker network expanding and promotional initiatives supporting growth.
Credit book surpassed €18.1 billion, increasing 7% year-over-year, with a very low NPL ratio of 0.82%.
Commercial volumes and managed asset inflows rose significantly, with net inflows up 7.8–8% and managed asset inflows up 47%.
Financial highlights
Net commission income increased 10% to €644.4 million, while net interest income declined 12% to €366.8 million due to higher funding costs and rate shifts.
Operating margin grew 1% to €570.6 million; contribution margin up 2% to €1,021.2 million.
Gross commission income rose 11% to €1,104.7 million, with management fees up 10% and banking service fees up 25%.
Loans granted surged 48% to €1.86 billion, driven by a 75% increase in mortgages.
General insurance gross premiums increased 23% to €114 million.
Outlook and guidance
Net interest income for 2025 expected to decrease by about 3% year-over-year, with stabilization anticipated in 2026.
Managed asset inflows guidance raised to €8–8.5 billion for 2025.
Cost/income ratio expected to remain below 40%; cost of risk guided at 20 basis points.
Dividend for 2025 anticipated to increase from the €0.75 per share base paid in 2024, with potential for a €0.20 special dividend from Mediobanca stake sale.
Latest events from Banca Mediolanum
- June net inflows reached €951 million, with strong managed asset growth and new client gains.BMED
Trading update9 Jul 2026 - Q1 2026 net income up 13% to €276.2M, with strong asset growth and resilient inflows.BMED
Q1 20268 Jul 2026 - Record net income and €10.44B inflows drive 42% dividend hike; 2025 inflows to stay strong.BMED
Q4 20248 Jul 2026 - Net income up 18% to €674.3M, assets at €133B, CET1 at 23.4%, interim dividend approved.BMED
Q3 20242 Jun 2026 - Net income up 24% to €449.9M, CET1 at 23.7%, and managed asset inflows guidance raised.BMED
Q2 20242 Jun 2026 - Net income up 10–10.4% YoY to €243.3m, with record inflows and strong capital ratios.BMED
Q1 20252 Jun 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025